---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-019528"
form_type: "8-K"
ticker: "CTXR"
cik: "0001506251"
company_name: "Citius Pharmaceuticals, Inc."
filed_at: "2022-04-13T23:59:59+00:00"
generated_at: "2026-06-26T07:39:31.064508+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Citius realigns management: Mazur named CEO; Holubiak becomes Exec. Vice Chairman for commercial launch

## Summary
- Leonard Mazur appointed CEO and Chairman; Myron Holubiak transitions to Executive Vice Chairman, effective May 1, 2022.
- Holubiak to lead commercial team for upcoming I/ONTAK (CTCL) launch and Mino-Lok Phase 3 completion.
- CFO Jaime Bartushak adds Chief Business Officer role; Michael McGuire joins as VP, Program Leader for Anti-Infectives.
- Holubiak enters amended employment agreement with $450K salary, 50% bonus potential, 18-month initial term.
- Company files Form 8-K; press release dated April 13, 2022, details the changes.

## SEC filing metadata
- accession: 0001213900-22-019528
- form_type: 8-K
- ticker: CTXR
- cik: 0001506251
- company_name: Citius Pharmaceuticals, Inc.
- filed_at: 2022-04-13T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506251/000121390022019528/0001213900-22-019528-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506251/000121390022019528/ea158351-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-019528
- JSON: https://secwatch.observer/filing/0001213900-22-019528.json
- Plain text: https://secwatch.observer/filing/0001213900-22-019528.txt

## Key facts
- Executive change
  Jaime Bartushak changed role as Chief Financial Officer and Chief Business Officer at Citius Pharmaceuticals, Inc..
  - Action: assume additional responsibilities as
  - Role: Chief Financial Officer and Chief Business Officer
  source text: Chief Financial Officer Jaime Bartushak will assume additional responsibilities as Chief Business Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506251/000121390022019528/0001213900-22-019528-index.htm
- Executive change
  Myron Holubiak was appointed as Executive Vice Chairman at Citius Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Executive Vice Chairman
  source text: the Board appointed Myron Holubiak, the current Chief Executive Officer, to the newly created position of Executive Vice Chairman
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506251/000121390022019528/0001213900-22-019528-index.htm
- Executive change
  Leonard Mazur was named as Chief Executive Officer and Chairman at Citius Pharmaceuticals, Inc..
  - Action: named
  - Role: Chief Executive Officer and Chairman
  source text: Leonard Mazur, Citius co-founder and Executive Chairman, has been named as Chief Executive Officer and Chairman.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506251/000121390022019528/0001213900-22-019528-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.